This is a very speculative and subjective question. The possibilities are endless. It could be a company like Resmed make a play for our OSA arm only but as has been outlined previously there are multiple players in this arena so a bidding war is not out of the question. I had a dream that Resmed offered 6 billion for our OSA drug combination, roughly $5 a share, and the BOD said ok but we will pay out $4 a share to shareholders and keep the other 1.2 billion to advance our other medicinal lines. Great dream.
IHL Price at posting:
72.5¢ Sentiment: Buy Disclosure: Held